HEALTH SCIENCES ACQUISITIONS CORP 2 HSAQ 深 滬
已收盤 01-26 16:00:00 美东时间
13.31
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 13.31
- 總市值 14.92万
- 52周最高 13.80
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 9.41
- 委 比 0.00%
- 總股本 1.12万
- 歷史最高 14.66
- 量 比 0
- 振 幅 0.00%
- 歷史最低 9.41
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Noveris Says No Operational Change Behind Surge in Trading Activity
Mydecine Innovations Group ( ($TSE:NVRS) ) has shared an announcement. Noveris ...
08-07 03:02
Hawkins, Inc. Increases its Quarterly Cash Dividend by 5% to $0.20 Per Share
Hawkins, Inc. announced on July 29, 2026, that its Board of Directors increased the quarterly cash dividend by 5% to $0.20 per share, payable on August 28, 2026, to shareholders of record as of August 14, 2026. The company has consistently paid dividends since 1985. Founded in 1938, Hawkins is a leading water treatment and specialty ingredients company with 66 facilities in 28 states, generating approximately $1.1 billion in revenue in fiscal 202...
07-29 20:05
Oracle Corp Stock (ORCL) Closed Down by 4.27% on Jul 24: What Signal Does It Send?
• Oracle shares declined amid sector-wide cloud migration concerns and macroeconomic inflationary pressures. • High capital expenditure for data center scaling creates investor uncertainty regarding long-term returns. • Technical indicators show an oversold condition while market sentiment remains in the bearish zone.
07-24 20:15
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer
Sunnybrook’s Odette Cancer Centre in Toronto has joined BriaCell’s pivotal Phase 3 clinical trial for metastatic breast cancer. The trial, which is evaluating Bria-IMT in combination with an immune checkpoint inhibitor, has over 80 active sites across the U.S. and now includes Canada. The study’s primary endpoint is overall survival, with an interim analysis planned. BriaCell recently received a positive recommendation from an independent Data Sa...
07-16 11:30
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
Emergent BioSolutions has been awarded a $52.7 million contract modification by the U.S. Department of Health and Human Services to supply ACAM2000® vaccine for smallpox and mpox preparedness. The company emphasizes its role in biodefense and highlights recent approvals in Saudi Arabia and Singapore for expanded use of the vaccine. ACAM2000® is indicated for high-risk individuals and carries important safety warnings, including potential serious ...
06-29 13:13
BlackRock Health Sciences Trust declares $0.2621 dividend
BlackRock Health Sciences Trust (BME) declares $0.2621/share monthly dividend. Forward yield 7.82% Payable July 31; for shareholders of record July 15; ex-div July 15. Payable Aug 31; for shareholders...
06-09 01:28
Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis
Apogee Therapeutics announced positive results from the Phase 2 APEX trial of zumilokibart in moderate-to-severe atopic dermatitis (AD), meeting primary and secondary endpoints with high statistical significance. Mid-dose zumilokibart showed the best clinical activity and tolerability, with plans for Phase 3 trials in 2H 2026. The drug demonstrated potential for less frequent dosing and robust efficacy, with plans to expand into asthma and eosino...
05-27 10:30
Novo Nordisk Says Wegovy Showed An Average 22.6% Weight Loss For Premenopausal Women With Obesity, With More Than 41% Achieving 25% Or More Weight Loss
Novo Nordisk is presenting a new sub-analysis from the large clinical trial STEP UP at the European Congress on Obesity (ECO) on 12-15 May in Istanbul, Türkiye, showing that the higher dose of the weight loss drug
05-12 18:34
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Market-Moving News for May 1st
AAPL: 4% | Apple shares are trading higher after the company reported better-than-expected Q2 financial results, issued Q3 sales guidance above estimates, announced a $100 billion share buyback, and raised its
05-01 19:16
